Alzheimer Disease Clinical Trials in Durham, North Carolina

4 studies are recruiting for alzheimer disease in Durham, North Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. ADRC Clinical Cohort (Alzheimer's Disease)

    The purpose of the study is to establish a clinical cohort for the Duke/UNC Alzheimer's Disease Research Center (ADRC). The cohort will be composed of subjects ages 25 to 44 at enrollment with normal cognition and subjects ages 45 to 80 at enrollment with normal cognition, mild cognitive impairment…

    Stage
    Not phased
    Ages
    25 to 80
    Site
    Duke University, Durham, North Carolina
    Run by
    Duke University

    See if you can join NCT06703541 on ClinicalTrials.gov

  2. A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

    The main purpose of this study is to evaluate the safety of LY3954068 in participants with early symptomatic Alzheimer's Disease (AD). The study will also investigate how much LY3954068 gets into the bloodstream and will test the effects of LY3954068 on markers of AD. The study will be comprised of…

    Stage
    Phase 1
    Ages
    50 to 85
    Site
    Duke University, Durham, North Carolina
    Locations
    10 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06297590 on ClinicalTrials.gov

  3. Olfactory Biopsies

    This research study aims to investigate the function of the olfactory lining in the nasal cavity and its potential alterations in both healthy and diseased conditions. The olfactory lining is involved in the sense of smell. The purpose of this study is to collect tissue from the nasal cavity.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Duke University Health Center, Durham, North Carolina
    Run by
    Duke University

    See if you can join NCT07021040 on ClinicalTrials.gov

  4. A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

    The main purpose of this study is to evaluate the safety and tolerability of the study drug known as LY4006895. Part A will administer a single-ascending dose in healthy participants or Part B will administer multiple-ascending doses in participants with early symptomatic Alzheimer's Disease (AD). …

    Stage
    Phase 1
    Ages
    45 to 85
    Site
    Duke Early Phase Research Unit, Durham, North Carolina
    Locations
    13 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06657768 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.